v3.25.2
Consolidated Statements of Shareholders' Equity - USD ($)
$ in Thousands
Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Other Comprehensive Loss [Member]
Accumulated Deficit [Member]
Total
Balance at Mar. 31, 2023 $ 1 $ 272,259 $ (6,038) $ (198,266) $ 67,955
Balance (in Shares) at Mar. 31, 2023 7,435,533        
Net loss $ 0 0 0 (12,853) (12,853)
Stock-based compensation 0 913 0 0 913
Issuance of common stock and pre-funded warrants through private placement, net of offering costs $ 0 5,707 0 0 5,707
Issuance of common stock and pre-funded warrants through private placement, net of offering costs (in Shares) 1,951,371        
Issuance of common stock upon the exercise of stock options $ 0 21 0 0 21
Issuance of common stock upon the exercise of stock options (in Shares) 12,500        
Balance at Mar. 31, 2024 $ 1 278,899 (6,038) (211,119) $ 61,743
Balance (in Shares) at Mar. 31, 2024 9,399,404       9,399,404
Issuance of common stock upon cashless exercise of pre-funded warrants $ 0 0 0 0 $ 0
Issuance of common stock upon cashless exercise of pre-funded warrants (in Shares) 740,457        
Net loss $ 0 0 0 (9,568) (9,568)
Stock-based compensation 0 730 0 0 730
Issuance of common stock and pre-funded warrants through private placement, net of offering costs $ 0 13,705 0 0 13,705
Issuance of common stock and pre-funded warrants through private placement, net of offering costs (in Shares) 3,252,132        
Issuance of common stock in exercise of pre-funded warrants $ 0 0 0 0 0
Issuance of common stock in exercise of pre-funded warrants (in Shares) 326,113        
Balance at Mar. 31, 2025 $ 1 $ 293,334 $ (6,038) $ (220,687) $ 66,610
Balance (in Shares) at Mar. 31, 2025 13,718,106       13,718,106